213 related articles for article (PubMed ID: 35215356)
1. Development of
García-Vázquez R; Jørgensen JT; Bratteby KE; Shalgunov V; Hvass L; Herth MM; Kjær A; Battisti UM
Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215356
[TBL] [Abstract][Full Text] [Related]
2. Direct Cu-mediated aromatic
García-Vázquez R; Battisti UM; Jørgensen JT; Shalgunov V; Hvass L; Stares DL; Petersen IN; Crestey F; Löffler A; Svatunek D; Kristensen JL; Mikula H; Kjaer A; Herth MM
Chem Sci; 2021 Sep; 12(35):11668-11675. PubMed ID: 34659701
[TBL] [Abstract][Full Text] [Related]
3. Optimization of Direct Aromatic
Andersen IV; García-Vázquez R; Battisti UM; Herth MM
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807267
[TBL] [Abstract][Full Text] [Related]
4. Development of the First Aliphatic
Battisti UM; Bratteby K; Jørgensen JT; Hvass L; Shalgunov V; Mikula H; Kjær A; Herth MM
J Med Chem; 2021 Oct; 64(20):15297-15312. PubMed ID: 34649424
[TBL] [Abstract][Full Text] [Related]
5. Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted
Stéen EJL; Jørgensen JT; Denk C; Battisti UM; Nørregaard K; Edem PE; Bratteby K; Shalgunov V; Wilkovitsch M; Svatunek D; Poulie CBM; Hvass L; Simón M; Wanek T; Rossin R; Robillard M; Kristensen JL; Mikula H; Kjaer A; Herth MM
ACS Pharmacol Transl Sci; 2021 Apr; 4(2):824-833. PubMed ID: 33860205
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Structurally Diverse
Adhikari K; Dewulf J; Vangestel C; Van der Veken P; Stroobants S; Elvas F; Augustyns K
ACS Omega; 2023 Oct; 8(41):38252-38262. PubMed ID: 37867688
[No Abstract] [Full Text] [Related]
7. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
[TBL] [Abstract][Full Text] [Related]
8. A New Highly Reactive and Low Lipophilicity Fluorine-18 Labeled Tetrazine Derivative for Pretargeted PET Imaging.
Keinänen O; Li XG; Chenna NK; Lumen D; Ott J; Molthoff CF; Sarparanta M; Helariutta K; Vuorinen T; Windhorst AD; Airaksinen AJ
ACS Med Chem Lett; 2016 Jan; 7(1):62-6. PubMed ID: 26819667
[TBL] [Abstract][Full Text] [Related]
9. Pretargeted imaging beyond the blood-brain barrier.
Shalgunov V; Lopes van den Broek S; Vang Andersen I; García Vázquez R; Raval NR; Palner M; Mori Y; Schäfer G; Herrmann B; Mikula H; Beschorner N; Nedergaard M; Syvänen S; Barz M; Moos Knudsen G; Battisti UM; Herth MM
RSC Med Chem; 2023 Mar; 14(3):444-453. PubMed ID: 36970152
[TBL] [Abstract][Full Text] [Related]
10. Tetrazine Glycoconjugate for Pretargeted Positron Emission Tomography Imaging of
Auchynnikava T; Äärelä A; Liljenbäck H; Järvinen J; Andriana P; Kovacs L; Rautio J; Rajander J; Virta P; Roivainen A; Li XG; Airaksinen AJ
ACS Omega; 2023 Dec; 8(48):45326-45336. PubMed ID: 38075748
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Evaluation of a Novel
Ruivo E; Elvas F; Adhikari K; Vangestel C; Van Haesendonck G; Lemière F; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
ACS Omega; 2020 Mar; 5(9):4449-4456. PubMed ID: 32175492
[TBL] [Abstract][Full Text] [Related]
12. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging.
Mandikian D; Rafidi H; Adhikari P; Venkatraman P; Nazarova L; Fung G; Figueroa I; Ferl GZ; Ulufatu S; Ho J; McCaughey C; Lau J; Yu SF; Prabhu S; Sadowsky J; Boswell CA
MAbs; 2018; 10(8):1269-1280. PubMed ID: 30199303
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Tetrazine Tracers for Pretargeted Imaging within the Central Nervous System.
Edelmann MR; Bredack C; Belli S; Mohr P; Imhoff MP; Reggiani F; Kusznir EA; Rufer AC; Holt DP; Valentine H; Wong DF; Dannals RF; Honer M; Gobbi LC
Bioconjug Chem; 2023 Oct; 34(10):1882-1893. PubMed ID: 37710950
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET.
Schlein E; Rokka J; Odell LR; van den Broek SL; Herth MM; Battisti UM; Syvänen S; Sehlin D; Eriksson J
EJNMMI Radiopharm Chem; 2024 Mar; 9(1):21. PubMed ID: 38446356
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Organo [
Otaru S; Imlimthan S; Sarparanta M; Helariutta K; Wähälä K; Airaksinen AJ
Molecules; 2020 Mar; 25(5):. PubMed ID: 32156020
[TBL] [Abstract][Full Text] [Related]
16. Pretargeted PET Imaging Using a Bioorthogonal
Billaud EMF; Belderbos S; Cleeren F; Maes W; Van de Wouwer M; Koole M; Verbruggen A; Himmelreich U; Geukens N; Bormans G
Bioconjug Chem; 2017 Dec; 28(12):2915-2920. PubMed ID: 29191024
[TBL] [Abstract][Full Text] [Related]
17. Development of a 99mTc-labeled tetrazine for pretargeted SPECT imaging using an alendronic acid-based bone targeting model.
Bohrmann L; Poulie CBM; Rodríguez-Rodríguez C; Karagiozov S; Saatchi K; Herth MM; Häfeli UO
PLoS One; 2024; 19(4):e0300466. PubMed ID: 38626058
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in the Development of Tetrazine Ligation Tools for Pretargeted Nuclear Imaging.
García-Vázquez R; Battisti UM; Herth MM
Pharmaceuticals (Basel); 2022 May; 15(6):. PubMed ID: 35745604
[TBL] [Abstract][Full Text] [Related]
19. Improved radiosynthesis and preliminary in vivo evaluation of the
Stéen EJL; Jørgensen JT; Petersen IN; Nørregaard K; Lehel S; Shalgunov V; Birke A; Edem PE; L'Estrade ET; Hansen HD; Villadsen J; Erlandsson M; Ohlsson T; Yazdani A; Valliant JF; Kristensen JL; Barz M; Knudsen GM; Kjær A; Herth MM
Bioorg Med Chem Lett; 2019 Apr; 29(8):986-990. PubMed ID: 30795854
[TBL] [Abstract][Full Text] [Related]
20. Tetrazine Carbon Nanotubes for Pretargeted In Vivo "Click-to-Release" Bioorthogonal Tumour Imaging.
Li H; Conde J; Guerreiro A; Bernardes GJL
Angew Chem Int Ed Engl; 2020 Sep; 59(37):16023-16032. PubMed ID: 32558207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
